Don’t miss the Rare Disease Innovation & Partnership Summit, March 21–23 in Philadelphia, PA, United States. You’ll connect with key stakeholders to drive therapeutic progress, propel commercial strategies and inspire impactful advocacy. 60+ expert speakers, including the FDA and C-Level Pharma/Bio execs, will discuss critical rare disease breakthroughs, and you’ll return to your office with solution-focused strategies surrounding patient access, reimbursement commercialisation, launch partnering and more.

You’ll hear from manufacturers, patients, advocates, regulators and leading experts as they cover content on topics such as understanding patient barriers, navigating the relationship between industry and advocacy, integrating racial disparity into the conversation, promoting partnerships and initiating developments to optimise access, understanding the role of patient support programmes, understanding the rise of cell and gene therapy, overcoming investment challenges, understanding the drug development process, global access pathways, managing alliances and partnerships, understanding patient centered outcomes measures, leveraging RWE for improved access and outcomes, increasing innovation in trial design, uncovering access to genomic sequencing, exploring expanded access programs, using AI and biomarkers to accelerate the drug development process, expanding the role of the specialty pharmacy, modernising the system to sustain newborn screening, and so much more!

Don’t miss the chance to come together with colleagues from around the globe to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.

Learn more at www.informaconnect.com/rare. Use code 23RAREREV10 to save 10%.

 

---